Cannabis Science Inc (CBIS) 0.0285 $CBIS American Green:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cannabis Science Inc (CBIS) 0.0285 $CBIS

American Green: A Partner to the Burgeoning Cannabis Industry
ACCESSWIRE - Tue Oct 06, 8:16AM CDT
SEATTLE, WA / ACCESSWIRE / October 6, 2015 / The prohibition of alcohol in 1919 was intended to eliminate many social problems, including drunkenness, crime, mental illness, and poverty. In reality, the opposite became true as organized crime filled the void of a legal market and consumers still met their needs. In 1933, the prohibition was repealed with the support of wealthy benefactors like John D. Rockefeller Jr. - a life-long non-drinker that contributed between $350,000 and $700,000.

Cannabis Industry Deals with Strict Laws & Regulations For Security & Surveillance Operations for Cannabis Facilities - Company Receives New Comprehensive Installation Project
PR Newswire - Tue Oct 06, 7:25AM CDT
The cannabis and legal marijuana industry continues to expand as more and more states come online with some level of the industry's operations. Newest improvements in grow operations, security advancements and product studies & announcements, Companies in focus with recent developments in the segment are DirectView Holdings, Inc. (OTC: DIRV), Medical Marijuana, Inc.(OTC: MJNA), American Green, Inc. (OTC: ERBB), Cannabis Science, Inc. (OTC: CBIS) & Hemp, Inc. (OTC: HEMP)

Recent National Cancer Institute Cannabis Reports Encourages Cannabis Science to Ramp Up California Product Releases, Bring More Products to Market in State by State Regulated Markets and Expedite Its Formal FDA Cancer Initiatives Much Faster
Marketwired - Mon Sep 28, 12:21PM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. Company specializing in cannabis-based pharmaceutical development, is ramping up its formal and informal Cancer studies in response to the National Cancer Institute initiatives to help save millions of preventable deaths each year by raising its Cancer Studies awareness and education about cancer. The Company is focused on persuading governments and individuals across the world to expand their preventive and therapeutic actions against Cancer and other critical ailments. Cannabis Science is highly motivated to accelerate the pace of its cancer drug development studies and is ramping up its new products distribution to the California market immediately through additional product releases and additional licensing deals in each state-by-state regulated market and its formal FDA initiatives.

CBIS Appoints Hon. Ronald V. Dellums, Chairman of the New International Government Affairs Board, Served 27 Years as a Highly Respected Member of the US House of Representatives, and Served as Chairman of the US House Armed Services Committee
Marketwired - Wed Sep 23, 6:57AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in cannabis formulation-based drug development, today announced that the world recognized advocate for peace and social justice, accomplished legislator, political leader, former chairman of the US House Armed Services Committee, and President of the Dellums Institute: Partners for Global Health + Justice, Hon. Ronald V. Dellums has been appointed the Chairman of the new International Government Affairs Board of CBIS.

Cannabis Science names Allen A. Herman, MB, ChB, PhD as CMO
M2 - Mon Sep 21, 3:44AM CDT
Drug development company Cannabis Science (OTCQB:CBIS) announced on Friday that it has elected Allen A. Herman, MB, ChB, PhD as its chief medical officer (CMO) as well continue as a member of the Scientific Advisory Board.

Cannabis Science Appoints Allen A. Herman, M.B., Ch.B., Ph.D., Former National Institute of Health (NIH) Scientist as Its Chief Medical Officer (CMO)
Marketwired - Fri Sep 18, 6:59AM CDT
Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company specializing in cannabis formulation-based drug development, today announced that accomplished scholar, epidemiologist, and public health physician Allen A. Herman, M.B., Ch.B., Ph.D. has been named as the Chief Medical Officer (CMO) of CBIS. Dr. Herman already serves on the Scientific Advisory Board of CBIS.

Cannabis Science Files Definitive Schedule 14C Filing to Officially Issue Dividend Payouts for Previous and Current Shareholders
Marketwired - Thu Sep 17, 2:28PM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce it has filed its Definitive Schedule 14C filing (RULE 14c-101) as the final steps to complete its dividend payout of the previously filed dividend share payout as filed with the S.E.C. on a Definitive Schedule 14C on August 18, 2011 and include all shareholders in on what the Company considers a landmark growth curve.

CBIS, CBRF, & CFA Announce the 2015 Ronald H. Brown African Affairs Series Held From September 14-19, 2015 in the Nation's Capital, Washington DC
Marketwired - Wed Sep 16, 12:32PM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce The Constituency for Africa (CFA) today announced its 2015 Ronald H. Brown (RHB) African Affairs Series that will be held from September 14-19, 2015 in the nation's capital. During the next four days the 2015 RHB African Affairs Series focuses on the theme of "Strengthening Capacity in Africa to Address Health, Economic, and Technology Challenges."

North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020
M2 - Mon Sep 14, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n7wcc2/north_america) has announced the addition of the "North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020" report to their offering. The North America Cannabis market is poised to grow from $ 3.46 billion in 2014 to $20.67 billion in 2020 at an estimated CAGR of 29.80% from 2015 to 2020. Factors like multifaceted applications of cannabis, expansion of licensing strategies, and automated irrigation system among others are driving this market towards growth. This market is also tackling some issues like volatile regulatory framework, absence of market leaders, perception towards marijuana, and environmental hazards among others. Owing to the fragmented supply chain and the presence of black market and perception issues, the cannabis market in North America has been estimated and forecasted strictly for the legal states, both for marijuana and hemp. The following pointers will encompass the scope of the research study and will lend a better understanding to the reader: - The total cannabis market is inclusive of the two primary derivatives namely-marijuana and Industrial Hemp - The market estimation for marijuana includes revenue from the legalized and active markets and Canada, where only medical marijuana is legalized - Certain states have legalized medical and recreational marijuana after 2013, however, there markets are not yet active and therefore, their market shares are not included in the total market size for the benchmark year (2014) - The report includes revenue for the marijuana market for all the active states having market share of above 0.5%. Rest of the state's revenue are clubbed as others - Through the forecast period, the other' states segment will also include the revenue from further states that are anticipated to legalize medical marijuana - The market size by application has been further segmented as applications of marijuana and industrial hemp for better clarity - The report includes the estimates of different entities of the cannabis ecosystem - The report also includes the optimistic revenue estimate for the benchmark year only for the U.S - Tax revenue estimate in case when marijuana is legalized across all the states in the U.S. has also been included Key Topics Covered: 1 Research Methodology, Scope And Coverage 2 Executive Summary 3 Introduction To North American Cannabis Market 4 Key Strategies And Development In The North American Cannabis Market (2013-2015) 5 Market Dynamics 6 North America Cannabis Industry Analysis 7 Regulatory & Legal Framework, Consortiums And Compliances 8 Market Sizing - Estimation, Analysis & Forecast By Derivative 9 Market Sizing- Estimation, Analysis & Forecast By Application 10 Market Sizing Analysis & Forecast, By Market Demand 11 Key Market Players Profiles - 22nd Century Group, Inc. - Abattis Bioceuticals Corporation - Advanced Cannabis Solutions - Affinor Growers - Agrisoft Development Group - Arena Pharmaceuticals, Inc. - Canadian Cannabis Corporation - Canna Brands Inc. - Canna Grow Holdings - Cannabics Pharmaceuticals Inc. - Cannabis Sativa Inc. - Cannabis Science, Inc. - Cannabis Therapy Corporation - Cannacare Docs - Cannavest - Dave - Eaze - Endexx Corporation - Equipment & Infrastructure - Frweed Pro - Grassp - Green Technology Solutions Inc. (Gtso) - Gw Pharmaceuticals - Hemp, Inc. - Information Technology - Insys Therapeutics - Leafly - Mass Roots - Meadow - Medbox, Inc. - Medical Marijuana Inc. - Nestdrop - Omnicanna Health Solutions - Otsuka Pharmaceutical Co. Ltd - Plandai Biotechnology - Privateer Holdings, Inc. - Quantum 9 - Sanofi Pharmaceuticals - Surna, Inc. - Tweed Marijuana Inc. - Weedmaps For more information visit http://www.researchandmarkets.com/research/n7...th_america
XXII: 1.08 (unch), INSY: 25.65 (+0.64), ARNA: 2.19 (+0.14)

DigiPath Pushes for Uniform Standards in Cannabis Testing
ACCESSWIRE - Thu Sep 10, 11:53PM CDT
SEATTLE, WA / ACCESSWIRE / September 11, 2015 / The cannabis industry could reach $35 billion in size by 2020, if all 50 states legalized marijuana and the federal government ended prohibition, according to GreenWave Advisors. Despite the industry's explosive growth, state governments have been slow to implement consistent regulations when it comes to cannabis safety standards, while the federal government has remained all but absent from any cannabis-related discussions.
MRK: 50.95 (-0.07)

Attention: Due Diligence offers Guidance for Shareholders
ACCESSWIRE - Wed Sep 09, 7:45AM CDT
NEW YORK, NY / ACCESSWIRE / September 9, 2015 / Broad Street Alerts reviewed the medical and recreational-use marijuana industry in the United States, specifically highlighting four companies. These companies include AeroGrow International, Inc. (OTCQB: AERO), GW Pharmaceuticals plc (NASDAQ: GWPH), Medbox, Inc. (OTCQB: MDBX), and Cannabis Science, Inc. (OTCBB: CBIS).
GWPH: 87.75 (+0.45)

Cannabis Science Files Preliminary Schedule 14C Filing to Officially Issue Dividend Payouts for Previous and Current Shareholders
Marketwired - Thu Sep 03, 8:02AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce it has filed its preliminary Schedule 14C filing as the next steps to complete its dividend payout of the previously filed dividend share payout as filed with the S.E.C. on a Definitive Schedule 14C on August 18, 2011 and include all shareholders in on what the Company considers a landmark growth curve.

Cashing in on Cannabis: CrowdGather's Smart Approach to Capturing Value From the Industry
ACCESSWIRE - Mon Aug 24, 7:00AM CDT
REDONDO BEACH, CA / ACCESSWIRE / August 24, 2015 / The cannabis industry could reach $35 billion in size by 2020, according to GreenWave Advisors, while it's generally considered to be the fastest growing industry in the U.S. economy. While these dynamics should make the industry ripe for investment, the murky legality of industry on a federal level and the opaque nature of many existing publicly-traded companies in the space (that went public through reverse mergers) have made it treacherous for investors.
GWPH: 87.75 (+0.45)

Cannabis Science to Issue Dividend Payouts for Previous and Current Shareholders, a $15-25 Million Capital Raise for FDA and Other Clinical Drug Development Programs as Well as a Proposed NASDAQ Up Listing
Marketwired - Tue Aug 18, 8:36AM CDT
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce the closure and issuance of the previously filed dividend share payout as filed with the S.E.C. on a Definitive Schedule 14C on August 18, 2011, the Definitive Schedule 14C filing (RULE 14c-101). The Company also intends to file another Information Statement to accommodate new shareholders to date to receive a similar dividend payout, to bring all shareholders in on what the Company considers a landmark growth curve. The Company expects to accelerate its current FDA targeted drug development programs and expand its State-by-State initiatives. Increasing shareholder value is of foremost importance for everyone involved; to this end the Company will apply for a unique trading symbol to accommodate a $15 - 25 million USD range financing it has been actively negotiating for the newly created class of dividend payout Common A stock, and formally pursue a contemplated up listing to NASDAQ. The Company expects to begin filing the complete new structure program with no reverse split by the end of the month.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 167

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Engrain's Geospatial Innovation Pushes Property Mapping Forward

Updated Category News Views 86

Pushing the Boundaries of Property Mapping How far can you expand the boundaries of property mapping tech? Well, Engrain seems hell-bent on finding out by cranking their innovations up a notch. The Denver-based stalwart in interactive mapping is rolling out some mind-boggling enhancements that could redefine how the multifamily housing sector operates. This isn't just...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 78

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 81

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 99

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
WHP Global's Japan Move: A Major Toy Market Play

Updated Category News Views 50

New Horizons for Toys"R"Us in Japan Well, folks, look who's back in the toy game with a vengeance! WHP Global is shaking hands with Pan Pacific International Holdings (PPIH) to breathe new life into Toys"R"Us across Japan. Now PPIH isn’t just any player. We're talking about Japan's fourth-largest retailer, helming giants like Don Quijote and aiming to crown itself as...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 16

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
Arbor Realty Trust Faces Securities Fraud Allegations

Updated Category News Views 5

Securities Lawsuit Against Arbor Realty Trust Looms Well, here we go again. Another day, another securities lawsuit hitting the headlines. This time it's Arbor Realty Trust (NYSE: ABR) getting caught in the crossfire, accused of pulling the wool over investors' eyes. Seems like 'truth in advertising' is just part of the PR playbook for some big shots. Understanding the...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 55

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 17

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading

Top 5 Most Recently Viewed Articles

Vizzy Hard Seltzer Unveils Exciting Cream Pop Variety Pack

Updated Category News Views 247

Vizzy Hard Seltzer Expands Flavor Options with New Variety Pack Vizzy Hard Seltzer is making waves by introducing its delightful Cream Pop Variety Pack, which marks a new chapter in its product line. This exciting pack is all set to enhance your sipping experience with flavors inspired by cherished childhood treats. Bringing together the well-loved Orange Cream Pop and...

Continue Reading
X-Bow Systems Expands DoD Partnership with New Funding Boost

Updated Category News Views 406

Significant Funding Boost for X-Bow Systems X-Bow Systems Inc. is making waves in the defense industry with its recent expansion of a crucial contract with the Department of Defense (DoD). This boost in funding follows a notable $64 million awarded in 2023 aimed at enhancing the production capacity of solid rocket motors. With this additional investment, X-Bow aims to...

Continue Reading
Digerati Technologies Mourns the Loss of Founding CEO Arthur Smith

Updated Category News Views 211

A Tribute to CEO Arthur L. Smith of Digerati Technologies Digerati Technologies, Inc. (OTC: DTGI), known for its dedicated approach to cloud services, recently lost its revered Founder and Chief Executive Officer, Arthur L. Smith. His passing has left a profound impact on the company, its employees, and the broader business community. Honoring a Visionary Leader Arthur L....

Continue Reading
Investors Encouraged to Engage in Transocean Ltd. Lawsuit

Updated Category News Views 142

Opportunity for Transocean Ltd. Investors Recent developments have opened a new chapter for investors of Transocean Ltd. (NYSE: RIG). Those who purchased securities between October 31, 2023, and September 2, 2024, referred to as the "Class Period," are now being called to action. This is a moment not just for individual investors, but a collective initiative to ensure...

Continue Reading
Blue Owl Capital Sets New Milestones with OWL Stock Growth

Updated Category News Views 144

Blue Owl Capital's Remarkable Stock Surge In a noteworthy display of market confidence, OWL stock has reached an impressive price level of $23.7, marking an all-time high. This significant milestone highlights the company's strong performance and the optimistic outlook investors have regarding its potential for growth. Over the last year, the company has experienced an...

Continue Reading